Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Cytokine|May 4, 2020
Association between VEGF gene promoter polymorphisms and bladder cancer: An updated meta-analysisChih-Heng Chen, Chen-Hsun Ho, Steven Kuan-Hua Huang, et al.
Plos One|June 21, 2016
Gene Therapy for Human Lung Adenocarcinoma Using a Suicide Gene Driven by a Lung-Specific Promoter Delivered by JC Virus-Like ParticlesChun-Nun Chao, Mien-Chun Lin, Chiung-Yao Fang, et al.
Journal of Virological Methods|April 3, 2012
Analysis of the size of DNA packaged by the human JC virus-like particleChiung-Yao Fang, Paul Yann Lin, Wei-Chih Ou, et al.
Virology|May 11, 2015
Global profiling of histone modifications in the polyomavirus BK virion minichromosomeChiung-Yao Fang, Cheng-Huang Shen, Meilin Wang, et al.
Molecular Medicine Reports|July 20, 2016
Evaluation of urinary bladder fibrogenesis in a mouse model of long-term ketamine injectionCheng-Huang Shen, Shou-Chieh Wang, Shou-Tsung Wang, et al.
Heliyon|May 19, 2023
Epigenetic regulation of human WIF1 and DNA methylation situation of WIF1 and GSTM5 in urothelial carcinomaCheng-Huang Shen, Pei-Yu Li, Shou-Chieh Wang, et al.
Heliyon|January 27, 2025
The potential synergistic effect of combining doxorubicin with vorinostat in urothelial carcinoma therapyCheng-Huang Shen, Shou-Chieh Wang, Kah-Min Lee, et al.
Urology|November 29, 2008
Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese populationYuan-Hung Wang, Hung-Yi Chiou, Chang-Te Lin, et al.
The American Journal of the Medical Sciences|July 13, 2011
Urothelial carcinoma in patients with advanced kidney disease: a 12-year retrospective cohort surveyPeir-Haur Hung, Cheng-Huang Shen, Hung-Bin Tsai, et al.
Disease Markers|March 21, 2014
Clinical significance of survivin expression in patients with urothelial carcinomaHsin-An Chen, Chih-Ming Su, Hsiao-Yen Hsieh, et al.
Pageof 10